Treatment of Resistant Langerhans Cell Histiocytosis With ENBREL

Completed · Phase 2

Conditions studied: Histiocytosis, Langerhans-Cell

In brief

The purpose of this study is to learn about the response of Langerhans cell histiocytosis (LCH) to Enbrel in patients who have failed to respond to standard therapies. We are also looking specifically at what side effects Enbrel has on patients. We expect to enroll 20 patients on this study and anticipate the subjects active participation to last up to one year.

Key facts

Study ID

NCT00048373

Run by

Baylor College of Medicine

People needed

20

Starts

2001-10-01

Expected to finish

2004-04-01

Last updated by the study team

2020-01-09

Who can join

Age: 0 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Texas Children's Hospital — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.